This statistic shows the value of the top U.S. biotech venture financings in 2017 (in million U.S. dollars). According to the data, Vir Biotechnology was financed in the amount of 500 million U.S. dollars.
Value of the top U.S. biotech venture financings in 2017
(in million U.S. dollars)
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Statista Accounts:
Access All Statistics. Starting from $468 / Year
Learn more about how Statista can support your business.
EY, & S&P Capital IQ, & BMO Capital Markets. (November 30, 2017). Value of the top U.S. biotech venture financings in 2017 (in million U.S. dollars) [Graph]. In Statista. Retrieved May 22, 2022, from https://www.statista.com/statistics/859020/biotech-venture-financing-amounts-us/
EY, und S&P Capital IQ, und BMO Capital Markets. "Value of the top U.S. biotech venture financings in 2017 (in million U.S. dollars)." Chart. November 30, 2017. Statista. Accessed May 22, 2022. https://www.statista.com/statistics/859020/biotech-venture-financing-amounts-us/
EY, S&P Capital IQ, BMO Capital Markets. (2017). Value of the top U.S. biotech venture financings in 2017 (in million U.S. dollars). Statista. Statista Inc.. Accessed: May 22, 2022. https://www.statista.com/statistics/859020/biotech-venture-financing-amounts-us/
EY, and S&P Capital IQ, and BMO Capital Markets. "Value of The Top U.S. Biotech Venture Financings in 2017 (in Million U.S. Dollars)." Statista, Statista Inc., 30 Nov 2017, https://www.statista.com/statistics/859020/biotech-venture-financing-amounts-us/
EY & S&P Capital IQ & BMO Capital Markets, Value of the top U.S. biotech venture financings in 2017 (in million U.S. dollars) Statista, https://www.statista.com/statistics/859020/biotech-venture-financing-amounts-us/ (last visited May 22, 2022)
